Clinical Trials Directory

Trials / Completed

CompletedNCT04225403

Telephone-based Motivational Interviewing for Smoking Cessation in Crohn's Disease Patients

Telephone-based Motivational Interviewing Delivered by IBD ( Inflammatory Bowel Disease) Nurses for Smoking Cessation in Crohn's Disease: a Randomized Open-label Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Quitting smoking unequivocally improves the course of Crohn's disease (EC), and therefore, it should be one of the main therapeutic targets in the treatment of this disease. The goal of the study was to know the effectiveness of motivational intervention 5 R for smoking cessation in patients with Crohn's disease performed by telephone by nursing, in relation to those who did not receive such intervention. For this purpose, a controlled, randomized, parallel and open clinical trial was designed. The subjects were patients with Crohn's disease that were actively smoking EC. They were all \>18 years old and they had internet access and e-mail. Those who were already in a process of smoking cessation were excluded from the study. Experimental intervention consisted of a motivational intervention for smoking cessation through telephone every 3 months for one year.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTelephone-based motivational interviewing for smoking cessationThe motivational brief intervention is known by the acronym 5 R and lasts about 5-10 minutes. It is an approach based on the principles of motivational interviewing and develops the intervention in five short steps: * Relevance. Help patients identify why personal reasons may be relevant to quitting smoking. * Risks. Help identify what negative consequences tobacco use has. * Rewards. Help identify potential benefits of quitting smoking. * Resistors. Help patients identify barriers to smoking cessation, which can often include fear of withdrawal symptoms, failure, wainweight, face social situations, etc. * Repeat. Repeat the intervention at 3 months if you do not advance at the stage of change.

Timeline

Start date
2015-11-06
Primary completion
2017-05-08
Completion
2017-05-08
First posted
2020-01-13
Last updated
2020-01-14

Source: ClinicalTrials.gov record NCT04225403. Inclusion in this directory is not an endorsement.